(firstQuint)CD5789 Long Term Safety Study on Acne Vulgaris.

 To determine the safety and efficacy of CD5789 50 mu g/g cream in the long-term treatment (up to 52 Weeks) of subjects with acne vulgaris.

 Efficacy will be evaluated as a secondary objective.

.

 CD5789 Long Term Safety Study on Acne Vulgaris@highlight

Multi-center, open-label, non-comparative safety and efficacy study with 52 Weeks of treatment on the face and trunk for acne vulgaris.

